Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced the launch of the Thermo Scientific™ Orbitrap™ Astral™ Zoom mass spectrometer (MS) and the Thermo ...

The research-grade Thermo Scientific ™ DXR3 Flex Raman Spectrometer is compatible with different analytical procedures. The tiny spectrometer shares the same architecture and optics as other ...

Scientific announced the launch of the Thermo Scientific Orbitrap Astral Zoom mass spectrometer and the Thermo Scientific ...

Seer Inc. (NASDAQ:SEER) announced a significant population-level study in collaboration with Korea University.

Bringing the power of Raman technology to the everyday analysis lab is the Thermo Scientific ™ DXR3 SmartRaman spectrometer, a dedicated, push-button operated, highly automated, macro-sampling Raman ...

HCG reported operating income at Rs 585.1 crore in Q4FY25, up from Rs 494.6 crore in the same period last year ...

Sail Biomedicines, a Flagship Pioneering company and leader in RNA-based programmable medicines, today announced that it will present new preclinical data from its malaria vaccine program at the 2025 ...

Lightcast, a pioneering life science tools company, today announced the appointment of Philip Binns as chairman of its board of directors, effective May 1, 2025. With this appointment, the Lightcast ...

A system that integrates all these techniques within a unified platform offers highly valuable versatility, enabling comprehensive sample analysis with increased confidence. Table 1. Vibrational ...

This product is the next step in spectrometer miniaturization and extended performance through state-of-the-art digital and high-frequency technologies. In October 2020, Thermo Fisher Scientific ...

These fundamental findings offer a novel mechanism by which rubrerythrin tubules encapsulate encapsulin to prevent oxidative stress in Pyrococcus furiosus. However, there are a few reasonable concerns ...

Healthcare Global Enterprises (HCG) reports decline in profitability, plans to invest in next-gen capabilities for oncology ...